First published in A Reasonable Rant: Private Edition (members-only subscription) on 5 Feb 2026.
In this episode, Neo steps away from the spectacle and into the system behind it, unpacking how the World Economic Forum influences what becomes visible, credible, and ultimately fundable. Drawing from observations in Zurich during Forum week and Startup Spectra’s global dataset (2020–2025), this episode examines the hidden mechanics of legitimacy, the role of platforms like UpLink, and the growing gap between narrative and actual capital movement.

What emerges is not a critique, but a structural insight. Davos does not deploy capital, it aligns it. And in doing so, it shapes how innovation is framed long before funding decisions are made. The problem is not whether the work matters. It’s whether it operates at a level that can meaningfully shift the system it sits inside.

First published in A Reasonable Rant: Private Edition (members-only subscription) on 29 Jan 2026.

In Episode 11, Neo unpacks one of venture capital’s least discussed pressure points: why so many companies that prove they can grow still fail to prove they can keep growing. This is not an episode about fundraising momentum or valuation milestones. It reframes Series B as a structural test, the point where startups stop being narratives about potential and become systems that must hold under real operational weight. Drawing on global venture data from 2020 to 2025, the episode shows that the sharp drop-off between Series B and Series C is not bad luck or founder failure, but a recurring pattern embedded in how companies are built and funded.

The core issue is misalignment. Startups do not move through clean stages, yet capital behaves as if they do. By the time companies reach Series B, they are often carrying unresolved problems from earlier phases, validation gaps, fragile processes, and unclear decision structures, while being expected to operate like fully coordinated systems. Growth continues, but coherence breaks. Costs rise unevenly, teams expand faster than structure, and what once looked like momentum begins to strain under its own weight. Capital, instead of recalibrating the system, often responds with pressure, optimising for efficiency where redesign is needed, which amplifies the very weaknesses it is trying to fix.

The episode ultimately reframes the Series B gap as a load-bearing failure in the venture model itself. It is not a shortage of capital, but a shortage of understanding and accommodation for what this stage actually demands. Geography sharpens the problem further, with emerging markets facing structural ceilings and misaligned expectations, while only a few ecosystems provide the depth of capital and patience required to absorb the transition. Series B is not a finish line. It is a crossing, and most companies are asked to carry more weight than they were ever designed to hold.

First published in A Reasonable Rant: Private Edition (members-only subscription) on 22 Jan 2026.
In Episode 10, Neo examines one of tech’s most persistent contradictions: how an industry with billions of users, extreme daily engagement, and more revenue than film and music combined still struggles to produce durable venture-backed companies. This is not a discussion about consoles or visuals, but about gaming as an economic system that behaves more like infrastructure than software. Revenue did not collapse. Players did not disappear. What broke was investor belief that scale in gaming could reliably translate into venture-style outcomes.

Using global funding data from 2020 to 2025 alongside firsthand experience building a national gaming operation in Central Africa, the episode shows how capital consistently miscategorised games as products rather than live social systems. Studios were funded to ship, not to operate. That mismatch becomes fatal in the space between Series B and Series C, where server costs, moderation risk, content pipelines, and community governance accelerate faster than capital can absorb. Fewer than half of gaming companies that reach Series B ever progress, not because the games fail, but because success creates operational weight most studios were never designed to carry.

The episode closes by resolving the paradox. Gaming did not fail venture capital. Venture capital misunderstood gaming. The most resilient companies were not the loudest or best funded, but those built for continuity, not exits. They aligned with how players already behave, treated games as places people return to, and survived when venture belief collapsed. Gaming did not lack value. It was measured with the wrong ruler.

In Episode 9, Neo looks past breach headlines and shiny tools to examine cybersecurity as a system of incentives, decisions, and structural blind spots. The episode begins with a personal identity fracture that quickly spirals across borders, banks, telecoms, and compliance systems, exposing how fragile digital identity becomes once it stops behaving “normally”.

Using an analysis of over 2,000 cybersecurity startups and more than 1,700 funding events between 2020 and 2025, representing roughly $74 billion in venture investment, the episode shows that this is not a story of underinvestment. It is a story of misalignment. Capital concentrated heavily around enterprise infrastructure and institutional buyers, while the everyday identity systems individuals rely on remained brittle, fragmented, and hard to recover when they fail.

Neo unpacks the quiet drop-off between Series B and Series C, where many security companies stall not because their technology is weak, but because the economics of selling security collide with reality. The episode also challenges the growing reliance on “AI-powered” security as comfort rather than clarity, and explains why trust in cybersecurity still follows geography more than technical robustness.

At its core, Episode 9 asks what security actually means in a world where systems protect organisations far better than people, and why the psychological cost of identity failure remains largely invisible, even as it quietly reshapes how we live and transact online.

Are accelerators actually making companies better, or just making them easier to sell?

In Episode 8, Neo digs into the uncomfortable gap between the accelerator myth and the post-demo-day reality. Drawing on first-hand experience designing and running programmes in sub-Saharan Africa, she traces how quickly “support” can turn into performance, and why polish is often mistaken for progress.

Then the data lands the punchline. Between January 2024 and mid-2025, Neo analysed 879 funding rounds where an accelerator or incubator appeared as an investor, tracking who raised, who progressed, and who quietly disappeared once the spotlight moved on. The pattern is clear: accelerators show up in meaningful deal volume, but not in proportional capital intensity. In other words, they can improve early legibility without guaranteeing late-stage durability.

This episode unpacks why the top 1–2% of programmes genuinely compound advantage, why most cannot, and how geography quietly tightens the funnel instead of widening it. You’ll hear why accelerators often compress the beginning but do not reliably solve the “middle” where unit economics, distribution, and operational resilience decide whether a business survives.

If you are a founder choosing between credibility and capability, an investor treating “accelerator-backed” as a shortcut, or an ecosystem builder designing programmes with real outcomes, this rant is a practical reset: accelerators are not neutral tools, they shape behaviour. The question is whether they are shaping it towards building real companies, or towards fundraising theatre.

Biotech does not run on software timelines. You cannot sprint biology, you cannot “growth hack” regulation, and you definitely cannot ship a patch when the product is inside a human being.

In this episode, Neo breaks down the uncomfortable mismatch between traditional venture capital’s speed instincts and biotech’s hard constraints, using fresh analysis of nearly 6,000 biotech and health-tech companies (almost 7,000 rounds, roughly $267B in announced investment) across 50+ countries from 2020 to 2025. Through a real investment decision inside a Chinese bone-regeneration startup, she shows why the biggest cheque is often the wrong choice, and why capability, manufacturing readiness, clinical access, and regulatory competence matter more than valuation optics.

China becomes the case study for what happens when biotech is treated as industrial capability rather than a speculative side quest, and why corporate venture capital can be a load-bearing beam when the “long, uncomfortable middle” arrives. If you care about what gets to real patients, this episode is your reality check: in biotech, money is fuel, but infrastructure is the engine.

The AI boom looks historic on the surface. Underneath, the structure tells a very different story.

In this episode, Neo examines what happens when capital flows in exactly the wrong direction. Drawing on analysis of more than 4,000 AI and machine learning startups and over $400 billion in disclosed funding between 2020 and 2025, she shows how a handful of mega-rounds came to dominate what we now call “innovation”.

Nineteen companies absorbed the vast majority of AI capital in 2024, while thousands of others competed for what remained. This rant unpacks why that kind of concentration feels exciting in real time, why it distorts behaviour across the ecosystem, and why the damage often only becomes visible years later.

Using a real marketplace case from the UAE, Neo traces how AI narratives collide with growth-stage reality in markets where Series B capital is scarce, infrastructure costs are high, and ownership of technology matters more than demos. From there, she zooms out to reveal a global pattern: capital clustering around foundation models and infrastructure, application-layer companies being starved of scale capital, and entire regions pushed into performative AI just to stay visible.

This is not an argument against AI. It is an argument about allocation, incentives, and endurance. If you are building, backing, or expanding AI companies and wondering why the boom feels loud but fragile, this episode explains why.

Product-market fit is treated like a verdict in startup culture. Neo argues it is nothing of the sort. In this episode, she reframes “fit” as a sequence of proofs that change by market, infrastructure, climate, and customer behaviour, then stress-tests the idea using food delivery as the clearest real-world case study.

Using fresh analysis of 590 food delivery companies that raised $28B globally between 2020 and 2025, Neo tracks where the story holds and where it collapses, especially at the Series A to Series B filter where optimism stops carrying the business. From Johannesburg’s trust-led reliability, to Kinshasa’s “good enough” certainty, Dubai’s integration-as-infrastructure, and China’s density-driven automation, this rant shows why copying someone else’s playbook is often just an expensive way to misunderstand your own market.

If you have ever asked “do we have product-market fit?”, this episode gives you the better question: what proof are we actually earning next, and will it still hold when subsidies, hype, and convenience disappear.

In this episode, Neo takes innovation on a global tour to examine how geography quietly shapes outcomes in ways our dominant frameworks fail to capture. From Africa’s discipline under scarcity to Southeast Asia’s capital efficiency, the Middle East’s deliberate experiment in enforced accountability, Europe’s structural leakage, Latin America’s resilience, and North America’s blind spots under abundance, this episode asks a sharper question than where innovation happens.

It shows how incentives, capital conditions, and local constraints determine what actually works, and why using universal metrics across non-universal realities leads us to fund familiarity instead of performance. If you have ever wondered why some overlooked ecosystems keep producing durable companies while celebrated ones struggle under scrutiny, this rant explains why.

What if the words we use to describe startup success are quietly misleading us?

In the first episode of A Reasonable Rant, Neo pulls apart the language that dominates the startup and venture world. Terms like scalable, innovative, AI-powered, platform, and product-market fit sound impressive, but often mean very different things depending on who is listening.

Drawing on nearly a decade working across Africa, Asia, the Middle East, and global venture markets, Neo explores how imprecise language hides risk, inflates confidence, and distorts decision-making. Not through hot takes or hype, but through lived experience, acquisition-room lessons, and hard data.

This is not a podcast about tearing startups down. It is about getting closer to what things actually are, so founders, investors, and ecosystem builders can make better decisions.

Part one of a three-part prologue series.
Part two looks at the data that breaks the narrative.
Part three asks what we should be measuring instead.

If you have ever felt that startup language sounds convincing but explains very little, this rant is for you.